Previous Close | 0.3601 |
Open | 0.4000 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.3601 - 0.3601 |
52 Week Range | 0.2185 - 1.0000 |
Volume | |
Avg. Volume | 561 |
Market Cap | 25.962M |
Beta (5Y Monthly) | 0.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3300 |
Earnings Date | May 01, 2023 - May 05, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, is pleased to announce, its support for the new client to improve access to quality, timely healthcare.
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, is pleased to announce that it has expanded its original $6.4 million contract announced on September 8, 2022, with a global pharmaceutical company by approximately $3.5 million, bringing the total value up to approximately $10 million.
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, today announced that it entered into an agreement with a new customer on January 30, 2023, to provide a broad range of software solutions, data and subscription services to help improve access to quality healthcare. The value of this engagement is approximately $2.0 million.